BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3840412)

  • 1. Inhibition of tumor promotion in mouse skin by 1 alpha,25-dihydroxyvitamin D3.
    Chida K; Hashiba H; Fukushima M; Suda T; Kuroki T
    Cancer Res; 1985 Nov; 45(11 Pt 1):5426-30. PubMed ID: 3840412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition by 1 alpha, 25-dihydroxyvitamin D3 of induction of epidermal ornithine decarboxylase caused by 12-O-tetradecanoylphorbol-13-acetate and teleocidin B.
    Chida K; Hashiba H; Suda T; Kuroki T
    Cancer Res; 1984 Apr; 44(4):1387-91. PubMed ID: 6423272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic inhibition of tumor promoter-induced ornithine decarboxylase in 1 alpha-hydroxyvitamin D3-treated animals.
    Hashiba H; Fukushima M; Chida K; Kuroki T
    Cancer Res; 1987 Oct; 47(19):5031-5. PubMed ID: 3621189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of combined treatments with selenium, glutathione, and vitamin E on glutathione peroxidase activity, ornithine decarboxylase induction, and complete and multistage carcinogenesis in mouse skin.
    Perchellet JP; Abney NL; Thomas RM; Guislain YL; Perchellet EM
    Cancer Res; 1987 Jan; 47(2):477-85. PubMed ID: 3098411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement by 1 alpha,25-dihydroxyvitamin D3 of chemically induced transformation of BALB 3T3 cells without induction of ornithine decarboxylase or activation of protein kinase C1.
    Sasaki K; Chida K; Hashiba H; Kamata N; Abe E; Suda T; Kuroki T
    Cancer Res; 1986 Feb; 46(2):604-10. PubMed ID: 3000580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol sulfate, a second messenger for the eta isoform of protein kinase C, inhibits promotional phase in mouse skin carcinogenesis.
    Chida K; Murakami A; Tagawa T; Ikuta T; Kuroki T
    Cancer Res; 1995 Nov; 55(21):4865-9. PubMed ID: 7585521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Regulation of tumor promotion by 1 alpha, 25-dihydroxyvitamin D3, an active form of vitamin D3].
    Kuroki T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):766-72. PubMed ID: 3754414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The protein kinase C activator L-alpha-dioctanoylglycerol: a potent stage II mouse skin tumor promoter.
    Verma AK
    Cancer Res; 1988 Apr; 48(7):1736-9. PubMed ID: 3127039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid.
    Huang MT; Ho CT; Wang ZY; Ferraro T; Lou YR; Stauber K; Ma W; Georgiadis C; Laskin JD; Conney AH
    Cancer Res; 1994 Feb; 54(3):701-8. PubMed ID: 8306331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate.
    Huang MT; Smart RC; Wong CQ; Conney AH
    Cancer Res; 1988 Nov; 48(21):5941-6. PubMed ID: 3139287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similarity and dissimilarity between phorbol ester tumor promoters and 1 alpha,25-dihydroxyvitamin D3, an active form of vitamin D3.
    Kuroki T; Suda T
    Princess Takamatsu Symp; 1983; 14():89-99. PubMed ID: 6394594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of both stage I and stage II mouse skin tumour promotion by retinoic acid and the dependence of inhibition of tumor promotion on the duration of retinoic acid treatment.
    Verma AK
    Cancer Res; 1987 Oct; 47(19):5097-101. PubMed ID: 3621194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of 12-O-tetradecanoylphorbol-13-acetate induction of ornithine decarboxylase activity, DNA synthesis, and tumor promotion in mouse skin by ascorbic acid and ascorbyl palmitate.
    Smart RC; Huang MT; Han ZT; Kaplan MC; Focella A; Conney AH
    Cancer Res; 1987 Dec; 47(24 Pt 1):6633-8. PubMed ID: 3677097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular and biochemical changes during multistage skin tumor promotion.
    Slaga TJ; Butler AP
    Princess Takamatsu Symp; 1983; 14():291-301. PubMed ID: 6394592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A flavonoid antioxidant, silymarin, affords exceptionally high protection against tumor promotion in the SENCAR mouse skin tumorigenesis model.
    Lahiri-Chatterjee M; Katiyar SK; Mohan RR; Agarwal R
    Cancer Res; 1999 Feb; 59(3):622-32. PubMed ID: 9973210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xanthorrhizol inhibits 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation and two-stage mouse skin carcinogenesis by blocking the expression of ornithine decarboxylase, cyclooxygenase-2 and inducible nitric oxide synthase through mitogen-activated protein kinases and/or the nuclear factor-kappa B.
    Chung WY; Park JH; Kim MJ; Kim HO; Hwang JK; Lee SK; Park KK
    Carcinogenesis; 2007 Jun; 28(6):1224-31. PubMed ID: 17234720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of 7-bromomethylbenz[a]anthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasone.
    Verma AK; Garcia CT; Ashendel CL; Boutwell RK
    Cancer Res; 1983 Jul; 43(7):3045-9. PubMed ID: 6406052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition by putrescine of the induction of epidermal ornithine decarboxylase activity and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate.
    Weekes RG; Verma AK; Boutwell RK
    Cancer Res; 1980 Nov; 40(11):4013-8. PubMed ID: 7471050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of anchorage-independent growth of JB6 mouse epidermal cells by 1 alpha,25-dihydroxyvitamin D3.
    Hosoi J; Abe E; Suda T; Colburn NH; Kuroki T
    Cancer Res; 1986 Nov; 46(11):5582-6. PubMed ID: 3019530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of initiator-promoter-induced skin tumorigenesis in female SENCAR mice fed a vitamin A-deficient diet and reappearance of tumors in mice fed a diet adequate in retinoid or beta-carotene.
    De Luca LM; Shores RL; Spangler EF; Wenk ML
    Cancer Res; 1989 Oct; 49(19):5400-6. PubMed ID: 2504490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.